Cargando...
A phase I trial of temsirolimus and pemetrexed in patients with advanced non-small cell lung cancer
BACKGROUND: Pemetrexed is an anti-folate chemotherapeutic agent approved for use in non-small cell lung cancer. Mammalian target of rapamycin (mTOR) pathway is implicated in lung cancer development, and is inhibited by temsirolimus. METHODS: We performed a phase I study evaluating the combination of...
Guardado en:
| Publicado en: | Chemotherapy |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5263044/ https://ncbi.nlm.nih.gov/pubmed/26780363 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000442147 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|